Global Influenza Diagnostics Market
Report Highlights
The global Influenza Diagnostics Market was valued at USD 508.87 million in 2016 and is projected to reach USD 1063.61 million by 2025, growing at a CAGR of 8.56% from 2017 to 2025.
With increasing prevalence of infectious diseases and initiatives towards treatment and efficient diagnosis of Influenza, the demand of diagnostic services has increased all over the globe. The market is thus expected to grow during the forecast period.
Market Dynamics:
1. Market Drivers
1.1 Increasing Prevalence of Influenza
1.2 Growth in Research Funding for Influenza Diagnostics
1.3 Rising Demand for Faster Diagnosis and Control of Influenza
2. Market Restraints
2.1 Variability in Sensitivity and Specificity Among Influenza Diagnostic Tests
2.2 Stringent Regulatory Framework
2.3 Rising Healthcare Costs Limiting the Usage of Novel Influenza Diagnostic Techniques
Market Segmentation:
1. Global Influenza DiagnosticsMarket, by End User:
1.1 Hospitals/Clinical Laboratories
1.2 Reference Laboratories
1.3 Other End Users
2. Global Influenza DiagnosticsMarket, by Test Type:
2.1 Traditional diagnostic tests
2.1.1 Rapid Influenza Detection Tests (RIDT)
2.1.2 Viral Culture
2.1.3 Direct Fluorescent Antibody (DFA) Tests
2.1.4 Serological Assays
2.2 Molecular Diagnostic tests
2.2.1 RT-PCR
2.2.2 Nucleic Acid Sequence-Based Amplification (NASBA) Tests
2.2.3 Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
2.2.4 Simple Amplification-Based Assays (SAMBA)
2.2.5 Other Molecular Diagnostic Tests
3. Global Influenza Diagnostics Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Becton, Dickinson and Company
3. Thermo Fisher Scientific Inc.
4. Alere Inc.
5. Diasorin S.P.A.
6. Quidel Corporation
7. Meridian Bioscience, Inc.
8. Analytik Jena AG (A Subsidiary of Endress+Hauser AG)
9. Luminex Corporation
10. SA Scientific, Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Influenza DiagnosticsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.